Cell and Gene Manufacturing and Logistics

  1. Preventing Costly Tubing Failures In Critical Processes 5/29/2026

    Reliable fluid transfer is critical in pharmaceutical processing. Find out how high-performance composite tubing enhances durability, maintains consistent flow, and minimizes contamination risks.

  2. Prevent Rupture In Challenging Peristaltic Pump Applications 5/29/2026

    Peristaltic pump tubing can be a hidden source of variability and risk. See how advanced composite designs offer stronger durability, cleaner performance, and steadier flow.

  3. Single-Use Disposable Containers For Bulk Lyophilization 5/29/2026

    Gain insight into a closed, membrane-based tray design that enhances containment during lyophilization, reducing contamination risks and cleanup demands for the efficient handling of compounds.

  4. Single-Use Containers For Secure Bulk Lyophilization 5/29/2026

    A better approach to freeze-drying minimizes product loss, contamination risk, and downtime. Discover enclosed, single-use systems that support efficient sublimation while protecting sensitive materials.

  5. Quality By Design: The Future Of Automated Pharmaceutical Labeling 5/28/2026

    Learn how applying Quality by Design principles to automated labeling platforms utilizes robotics to eliminate manual errors and seamlessly adapt to future pharmaceutical packaging formats.

  6. The Cornerstones Of Cell Therapy Excellence 5/28/2026

    Cell therapy success relies on integrated analytics, process development, quality, and manufacturing, using risk management and DoE strategies to ensure scalable, compliant, cost-effective delivery.

  7. Navigating Intensifying Cell Therapy Regulatory Expectations 5/28/2026

    Rising regulatory demands require strong CMC, validated analytics, and inspection-ready operations. Early alignment of quality, scalability, and risk management is key to cell therapy commercialization.

  8. Setting A New Standard For Biotech Program Visibility 5/27/2026

    Biotech visibility improves through real-time data and centralized platforms, enabling collaboration, faster decisions, reduced risk, and better partner alignment.

  9. 5 Operational Gaps To Avoid CGT Patient Risks 5/27/2026

    Examine five critical supply chain gaps in cell and gene therapy logistics that put patients at risk, from invisible operational burdens to reactive monitoring and fragmented coordination strategies.

  10. Speeding Up Safety: An Evaluation Of Mycoplasma Technology 5/27/2026

    Rapid mycoplasma testing enhances cell and gene therapy safety by reducing turnaround time, minimizing sample needs, and delivering sensitive, reliable contamination detection across diverse matrices.